Algo version: 0.98b
Beijing Succeeder is listed at the SHH Exchange
Beijing Succeeder [688338.SS]
SHH Sector: Healthcare Industry:Medical Devices

Is Beijing Succeeder stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Beijing Succeeder pays dividends. Last time was Thursday 6th of June 2024 where the investors holding the stock on Thursday 6th of June 2024 were paid CNY0.26 per share. Over the last 4 times between 2021 and 2024, Beijing Succeeder has paid CNY1.248 with an average of CNY0.31 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Beijing Succeeder 10 years ago, but if you had invested on Thursday 6th of August 2020 when the price was CNY130.91, you would have made a loss of CNY-110.13 per share or -84.13%

Yes, the average daily trading liquidity for Beijing Succeeder is CNY477 598 thousand. You should therefore be able to get in and out of your positions relatively fast.

Beijing Succeeder has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 736.16, the company's ability to pay off the debt is good. Beijing Succeeder has a very good net profit margin of 42.68% and should have very high tolerances against inflation.

We have calculated the inflation risk for Beijing Succeeder to be low [0 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.